drugset / Trial / NCT04226898
Synbiotic Compound to Reduce Symptoms of Schizophrenia
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine if taking a synbiotic supplement versus a placebo will reduce symptoms of schizophrenia when used in addition to standard antipsychotic medications.
Timeline
- Start
- 2022-02-21
- Primary completion
- 2027-03
- Completion
- 2027-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Probio-Tec ABCG-Stick-25 | Other / unclassified | 1 unknown | Oral |